Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Malignant Mesothelioma and Its Nonasbestos Causes.

Finkelstein MM.

Arch Pathol Lab Med. 2019 Jun;143(6):659-660. doi: 10.5858/arpa.2018-0145-LE. No abstract available.

PMID:
31121110
2.

A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans.

Finkelstein MM.

Toxicol Appl Pharmacol. 2019 May 15;371:1-2. doi: 10.1016/j.taap.2019.03.023. Epub 2019 Apr 1.

PMID:
30946862
3.

Response to: 'The epidemiology of malignant mesothelioma in women: gender differences and modalities of asbestos exposure' by Marinaccio et al.

Finkelstein MM.

Occup Environ Med. 2018 Nov;75(11):844. doi: 10.1136/oemed-2018-105129. Epub 2018 Sep 12. No abstract available.

PMID:
30209210
5.

Reanalysis of non-occupational exposure to asbestos and the risk of pleural mesothelioma.

Finkelstein MM.

Occup Environ Med. 2018 Jun;75(6):472-473. doi: 10.1136/oemed-2017-104783. Epub 2017 Dec 29. No abstract available.

PMID:
29289945
6.
7.

Re: Mortality of Talc Miners and Millers From Val Chisone, Northern Italy.

Finkelstein MM.

J Occup Environ Med. 2017 Oct;59(10):e194. doi: 10.1097/JOM.0000000000001139. No abstract available.

PMID:
28991139
8.

In reference to Asbestos exposure and laryngeal cancer mortality.

Finkelstein MM.

Laryngoscope. 2017 Mar;127(3):E114. doi: 10.1002/lary.26120. Epub 2016 Oct 21. No abstract available.

PMID:
27767212
9.

Historical ambient airborne asbestos concentrations in the United States.

Finkelstein MM.

Inhal Toxicol. 2016 Aug;28(10):429-30. doi: 10.1080/08958378.2016.1203045. Epub 2016 Jul 17. No abstract available.

PMID:
27427157
10.
11.

How physicians can survive the "perfect storm" developing in healthcare today--and thrive.

Saxton JW, Pawlson G, Finkelstein MM.

J Med Pract Manage. 2013 Nov-Dec;29(3):167-71.

PMID:
24765734
12.

Statins and musculoskeletal adverse events.

Finkelstein MM.

JAMA Intern Med. 2014 Feb 1;174(2):302. doi: 10.1001/jamainternmed.2013.12697. No abstract available.

PMID:
24493607
13.

The analysis of asbestos count data with "nondetects": the example of asbestos fiber concentrations in the lungs of brake workers.

Finkelstein MM.

Am J Ind Med. 2013 Dec;56(12):1482-9. doi: 10.1002/ajim.22262. Epub 2013 Sep 20.

PMID:
24115084
14.

Letter to the Editor re Bernstein et al: Health risk of chrysotile revisited. Crit Rev Toxicol, 2013; 43(2): 154-183.

Finkelstein MM.

Crit Rev Toxicol. 2013 Sep;43(8):707-8. doi: 10.3109/10408444.2013.825762. No abstract available.

PMID:
23985074
15.

Pneumoconiosis and malignant mesothelioma in a family operated metal casting business that used industrial talc from New York state.

Finkelstein MM.

Am J Ind Med. 2013 May;56(5):550-5. doi: 10.1002/ajim.22159. Epub 2013 Feb 28.

PMID:
23450672
16.

Be prepared in the post-PPACA liability and healthcare environment: assure, do not assume.

Saxton JW, Finkelstein MM.

J Med Pract Manage. 2012 Sep-Oct;28(2):101-5. No abstract available.

PMID:
23167023
17.

Letter concerning the paper by Finley and colleagues: dx.doi.org/10.1016/j.yrtph.2012.05.015.

Finkelstein MM.

Regul Toxicol Pharmacol. 2013 Feb;65(1):178-9. doi: 10.1016/j.yrtph.2012.08.016. Epub 2012 Aug 27. No abstract available.

PMID:
22960065
18.

Use HCAHPS as a motivator to reenergize your five-star program, and make it personal.

Saxton JW, Finkelstein MM.

J Med Pract Manage. 2012 May-Jun;27(6):365-70.

PMID:
22834185
19.

Malignant mesothelioma incidence among talc miners and millers in New York State.

Finkelstein MM.

Am J Ind Med. 2012 Oct;55(10):863-8. doi: 10.1002/ajim.22063. Epub 2012 Apr 27.

PMID:
22544543
20.

A culture of safety: a business strategy for medical practices.

Saxton JW, Finkelstein MM, Marles AF.

J Med Pract Manage. 2012 Jan-Feb;27(4):237-43.

PMID:
22413601
21.

Mortality among subjects with chronic obstructive pulmonary disease or asthma at two respiratory disease clinics in Ontario.

Finkelstein MM, Chapman KR, McIvor RA, Sears MR.

Can Respir J. 2011 Nov-Dec;18(6):327-32.

22.

Test tracking: patient safety as a quality-improvement and liability-reduction strategy.

Saxton JW, Finkelstein MM, Unger SS.

J Med Pract Manage. 2011 Sep-Oct;27(2):92-7. No abstract available.

PMID:
22111280
23.

Safety works: getting past the very thought of change.

Saxton JW, Finkelstein MM.

J Med Pract Manage. 2011 May-Jun;26(6):377-81. No abstract available.

PMID:
21815556
24.

Taking patient accountability to another level: because healthcare reform makes it necessary.

Saxton JW, Finkelstein MM.

J Med Pract Manage. 2011 Jan-Feb;26(4):258-60. No abstract available.

PMID:
21506471
25.

Healthcare reform: can you get ahead of the wave?

Saxton JW, Finkelstein MM.

J Med Pract Manage. 2010 Sep-Oct;26(2):121-4. No abstract available.

PMID:
21090210
26.

Five-star lessons learned: how to move up the curve in today's environment.

Saxton JW, Finkelstein MM.

J Med Pract Manage. 2010 May-Jun;25(6):386-9. No abstract available.

PMID:
20695254
27.
28.

Lung cancer in the melt shops of Ontario steelmakers.

Finkelstein MM.

Am J Ind Med. 2010 Jul;53(7):762. doi: 10.1002/ajim.20848. No abstract available.

PMID:
20583139
29.

Malignant mesothelioma among employees of a Connecticut factory that manufactured friction materials using chrysotile asbestos.

Finkelstein MM, Meisenkothen C.

Ann Occup Hyg. 2010 Aug;54(6):692-6. doi: 10.1093/annhyg/meq046. Epub 2010 Jun 3.

PMID:
20522518
30.

Depression severity and effect of antidepressant medications.

Finkelstein MM.

JAMA. 2010 Apr 28;303(16):1596-7; author reply 1599. doi: 10.1001/jama.2010.505. No abstract available.

PMID:
20424242
31.

A cohort study of traffic-related air pollution and mortality in Toronto, Ontario, Canada.

Jerrett M, Finkelstein MM, Brook JR, Arain MA, Kanaroglou P, Stieb DM, Gilbert NL, Verma D, Finkelstein N, Chapman KR, Sears MR.

Environ Health Perspect. 2009 May;117(5):772-7. doi: 10.1289/ehp.11533. Epub 2009 Jan 5.

32.

Five-star service culture: enhancing satisfaction and reducing liability exposure.

Saxton JW, Finkelstein MM.

J Med Pract Manage. 2008 Nov-Dec;24(3):135-8.

PMID:
19146080
33.

Ethics training needs to emphasize disclosure and apology.

Wojcieszak D, Saxton JW, Finkelstein MM.

HEC Forum. 2008 Sep;20(3):291-305. doi: 10.1007/s10730-008-9077-2. No abstract available.

PMID:
18803017
34.

Adverse event management: your evidence to decrease professional liability risk.

Saxton JW, Finkelstein MM.

J Med Pract Manage. 2008 Jul-Aug;24(1):5-8.

PMID:
18754243
35.

Asbestos fibre concentrations in the lungs of brake workers: another look.

Finkelstein MM.

Ann Occup Hyg. 2008 Aug;52(6):455-61. doi: 10.1093/annhyg/men036. Epub 2008 Jun 23.

PMID:
18573807
36.

Effectiveness of selective serotonin reuptake inhibitors.

Finkelstein MM.

CMAJ. 2008 Apr 22;178(9):1185; author reply 1185-6. doi: 10.1503/cmaj.1080023. No abstract available.

37.

Diesel particulate exposure and diabetes mortality among workers in the Ontario construction trades.

Finkelstein MM.

Occup Environ Med. 2008 Mar;65(3):215. doi: 10.1136/oem.2007.035774. No abstract available.

PMID:
18283128
38.

The relationship between diabetes mellitus and traffic-related air pollution.

Brook RD, Jerrett M, Brook JR, Bard RL, Finkelstein MM.

J Occup Environ Med. 2008 Jan;50(1):32-8. doi: 10.1097/JOM.0b013e31815dba70.

PMID:
18188079
39.

How a successful litigator decides whether or not to sue you.

Saxton JW, Finkelstein MM.

J Med Pract Manage. 2007 Sep-Oct;23(2):90-3.

PMID:
17974085
40.
41.

Avoiding medicolegal complications.

Cotton PB, Saxton JW, Finkelstein MM.

Gastrointest Endosc Clin N Am. 2007 Jan;17(1):197-207, ix.

PMID:
17397785
42.

Modeling the intraurban variability of ambient traffic pollution in Toronto, Canada.

Jerrett M, Arain MA, Kanaroglou P, Beckerman B, Crouse D, Gilbert NL, Brook JR, Finkelstein N, Finkelstein MM.

J Toxicol Environ Health A. 2007 Feb 1;70(3-4):200-12.

PMID:
17365582
43.

Modelling continuous data.

Finkelstein MM.

CMAJ. 2005 Sep 27;173(7):733. No abstract available.

44.

Environmental inequality and circulatory disease mortality gradients.

Finkelstein MM, Jerrett M, Sears MR.

J Epidemiol Community Health. 2005 Jun;59(6):481-7.

45.
46.

A cohort study of mortality among Ontario pipe trades workers.

Finkelstein MM, Verma DK.

Occup Environ Med. 2004 Sep;61(9):736-42.

47.

Current man-made mineral fibers (MMMF) exposures among ontario construction workers.

Verma DK, Sahai D, Kurtz LA, Finkelstein MM.

J Occup Environ Hyg. 2004 May;1(5):306-18.

PMID:
15238339
48.

Traffic air pollution and mortality rate advancement periods.

Finkelstein MM, Jerrett M, Sears MR.

Am J Epidemiol. 2004 Jul 15;160(2):173-7.

PMID:
15234939
49.

Ischemic heart disease mortality among heavy equipment operators.

Finkelstein MM, Verma DK, Sahai D, Stefov E.

Am J Ind Med. 2004 Jul;46(1):16-22.

PMID:
15202121
50.

Supplemental Content

Loading ...
Support Center